Monitoring

Eosinophilic oesophagitis (EoO) is a chronic condition. Monitoring can vary depending on the treatment and the individual features of the patient. Assessment of symptomatic, endoscopic, and histological outcomes is recommended to evaluate response to treatment.[3][82]​ Repeat oesophagogastroduodenoscopy (OGD) to assess endoscopic and histological disease activity is recommended after initiating or changing treatment, or with a change or worsening in clinical status.​​​​[3]​​[27]

Symptoms only modestly correlate with other measures of disease activity.[178]​ When EoO is in remission and well controlled, regular clinic visits (i.e., every 3-6 months in children, particularly to monitor growth and nutrition, and every 6-12 months in adults) are required. There are no formal recommendations on routine endoscopic surveillance, and this practice varies depending on the centre.

Use of this content is subject to our disclaimer